SEC Filings

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

Filing date Form Description View
PREM14A

A preliminary proxy statement relating to a merger or acquisition

10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A

Additional proxy soliciting materials - definitive

DEFA14A

Additional proxy soliciting materials - definitive

8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A

Additional proxy soliciting materials - definitive

DFAN14A

Additional proxy soliciting materials filed by non-management

DEFA14A

Additional proxy soliciting materials - definitive

DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

4

Statement of changes in beneficial ownership of securities

Data provided by Kaleidoscope.

Shareholder Tools